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A BST R AC T   
 
Aim: To compare hemogram-mediated inflammatory markers such as mean platelet volume (MPV), 
red cell distribution width (RDW), platelet distribution width (PDW), neutrophil to lymphocyte ratio 
(NLR), platelet to lymphocyte ratio (PLR), MPV to platelet ratio (MPR) and RDW to platelet ratio 
(RPR) in predicting outcome in the intensive care units (ICU) population.  
Methods: After obtaining approval of intuitional board the patients whom were treated in the 
Anesthesiology and Reanimation ICU of Bolu Abant Izzet Baysal University Hospital between 
March 2017 and December 2018 were evaluated retrospectively and enrolled to the study. The above-
mentioned laboratory parameters of the deceased and survivors were compared. 
Results: The PDW, MPV, C-reactive protein (CRP), RPR and MPR values were significantly 
different between deceased and survived subjects. Moreover, MPV and PDW values were 
significantly and positively correlated with serum CRP level. 
Conclusion: We suggest that PDW, MPV, MPR and RPR could be used in determining the severity 
of the disease in ICU patients along with CRP. Since these hemogram results could be obtained in a 
much shorter time period compared to CRP, they could be useful in this population; in which hours 
and even minutes are important in the treatment in ICU. 
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Introduction 
Intensive care units (ICU) make an important 
part of the sophisticated hospitals by the 
patients residents demand attentive care. 
Despite careful and elaborating care in ICU, 
mortality of these patients are far higher than 
other patients receive inpatient treatment.   
Various scoring systems are used to determine 
the clinical course with less invasive method 
and to predict the risk of mortality in ICU 
patients. Several inflammatory biomarkers, 
including, C- reactive protein (CRP) and 
procalcitonin, suggested to be predictors of 
mortality in these patients [1]. In addition, 
recent studies emphasized the role of 
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hemogram indices in predicting morbidity and 
mortality in ICU. These indices include mean 
platelet volume (MPV), red cell distribution 
width (RDW), platelet distribution width 
(PDW), and neutrophil to lymphocyte ratio 
(NLR), platelet to lymphocyte ratio (PLR), 
MPV to platelet ratio (MPR) and RDW to 
platelet ratio (RPR) [2-6]. 
In present retrospective analysis, we aimed to 
study hemogram derived inflammatory indices 
(MPV, RDW, MPR, RPR, PLR and NLR) in 
intensive care population and to compare them 
in the groups consisted of deceased and 
survived subjects to investigate whether they 
could predict mortality in ICU.  
 
Methods 
After approval of the local ethics committee, 
the patients whom were treated in the 
Anesthesiology and Reanimation ICU of Abant 
Izzet Baysal University Hospital between 
March 2017 and December 2018 were 
evaluated retrospectively and enrolled to the 
study. Patients who were hospitalized within 
the last month were excluded from the study. 
The indications for admission to ICU, age and 
gender of the subjects, comorbid diseases, and 
duration of hospitalization were recorded. The 
indications for intensive care were classified as 
systemic disease and malignancy. The 
treatment results of the patients were 
determined as survived or deceased and the 
study population was grouped accordingly. 
Biomarkers to predict mortality were calculated 
from blood samples taken at the time of 
hospitalization in ICU. 
Parameters viewed from hemogram 
measurements; Fasting blood glucose (FPG), 
CRP, leukocyte count (WBC), neutrophil count 
(NC), lymphocyte count (LC), hemoglobin 
(Hb), hematocrit (Htc), platelet count (PltC), 
RDW, platelet distribution width (PDW), MPV 
values were obtained from database and 
recorded. NLR was calculated by simply 
dividing of NC to LC. PLR was calculated by 
division of PltC to LC. MPR calculated by 
division of MPV to PltC. Finally, RPR 
calculated by division of RDW to PltC.  
Statistically analyses performed by SPSS 
software (SPSS 15.0 for Windows, IBM Inc, 
Chicago, IL, USA). Comparison of the 
variables in study groups were conducted by 
Mann-Whitney U Test or by independent 
samples t test. Categorical variables were 
conducted with Chi-Square test. Pearson’s 
correlation test was used to evaluate correlation 
between study variables and CRP. The 
significance were set on a p value less than 
0.05. 
 
Results  
A total of 174 patients were included in the 
study (99 male and 75 female). Gender was not 
significantly different between deceased and 
survived patients in terms of gender (p=0.27). 
Median ages of the survived and deceased 
patients were 68 (16-96) years and 73 (33-94) 
years, respectively. The age difference between 
survived and deceased subjects was statistically 
significant (p=0.03). 149 patients were 
admitted to the ICU with the diagnosis of 
systemic disease and 25 patients with 
malignancy. 42% of the patients hospitalized 
because of systemic diseases were deceased, 
while this rate was 32% in the patients 
hospitalized because of malignancy. The 
incidence of systemic disease and malignancy 
in deceased and survived patients groups was 
not statistically different (p=0.16). 
The hospitalization period of the survived and 
deceased patients were 3 (1-118) days and 6 (1-
97) days, respectively (p=0.003). Comorbidity 
rate in survived and deceased patients were 
63% and 78%, respectively (p=0.03).  
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When the presence of additional disease was 
examined as single or multiple, 35% of 
survivors had single additional disease and 65% 
had multiple additional diseases. In 46% of the 
patients who died, 56% had multiple additional 
diseases. The difference between the groups in 
terms of single or multiple additional disease 
was not statistically significant (p = 0.30). 
Wbc (p = 0.94), NC (p = 0.84), LC (p = 0.62), 
MCV (p = 0.53), RDW (p = 0.08), Plt (p = 
0.08) were examined. Flow (p=0.66), 
monocyte (p = 0.61), pct (p = 0.68), NLR (p = 
0.94), PLR (p = 0.29), MLR (p = 0.28), MOLR 
(p = 0.94) values groups was not different 
between. Hb (p = 0.01), Hct, (p = 0.02) values 
were significantly higher in surviving patients 
than those who died. 
The PDW values of the surviving and dying 
patients were 18 (16-23) % and 18 (15-23) %, 
respectively (p=0.01). MPV values of 
surviving and dying patients were 8 (5-15) fL 
and 8.5 (6-15) fL, respectively (p=0.02). CRP 
values of surviving and dying patients were 
32.5 (1-333) units and 117 (1-336) units, 
respectively (p <0.001). RPR values of 
surviving and dying patients were 8 (3-42) % 
and 9 (2-96) %, respectively (p=0.03). MPR  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
values of surviving and dying patients were 3 
(1-24) % and 5 (1-63) %, respectively (p=0.02). 
Mean MPV (r=0.20, p=0.009) and PDW 
(r=0.24, p=0.001) values showed significant 
positive correlation with serum CRP level. 
 
Discussion 
Present study showed that along with CRP, a 
well-defined inflammatory marker, PDW, 
MPV, RPR and MPR elevation could also be 
predictors of mortality in ICU population. 
Recent studies showed significant association 
between MPV and malignant and inflammatory 
diseases [7]. MPV has been suggested as an 
indicator of platelet activity, and there is strong 
evidence that MPV may have an important 
hemogram indice, which means that larger 
platelets are more active than normal platelets. 
[8]. MPV has role in both obesity and 
inflammation [9]. Since platelets have 
important role in angiogenesis of malignant 
masses, MPV could be involved in such 
reactions. Moreover it has been suggested to be 
associated with mortality in respiratory ICU 
population [10]. In a previous study of ours, we 
have found increased MPV in deceased ICU 
patients compared to survived patients [11].  
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In literature, elevated CRP has been found to be 
associated with decreased survival [12]. We 
shall speculate that as another inflammatory 
marker, MPV could be increased with greater 
inflammatory burden in mortal cases compared 
to non-mortal situations. 
PDW is introduced as an associated hemogram 
marker with pulmonary tuberculosis [13]. 
Moreover, the authors reported that treatment 
of tuberculosis reduce the increased levels of 
PDW [14].  
Elevated PDW levels have been reported in 
patients with obstructive sleep apnea syndrome 
[15].   
There are also conflicting reports about PDW in 
literature, such as Ozdemir et al’s study, which 
concluded that there was no change in PDW 
levels before and after treatment in subjects 
with acute rheumatic carditis [16]. Authors 
found elevated MPR in subjects with 
hepatosteatosis compared to those without 
hepatosteatosis [17]. In that study, increased 
MPR levels in hepatosteatosis reflect the 
burden of inflammation and was correlated 
with plasma glucose and LDL cholesterol, 
which are also associated with hepatosteatosis 
[17]. Authors suggested PDW as an 
inflammatory marker in type 2 diabetes 
mellitus [18]. In addition, it has been reported 
that MPR increased in patients with ST 
elevation myocardial infarction and with 
infective endocarditis [19,20]. MPR was 
considered as a marker of inflammatory burden 
in another study in literature [21]. Several 
studies in literature suggested the relation 
between MPR and inflammatory conditions. 
MPR was also associated with irritable bowel 
disease, a condition that associated with low 
grade inflammation [2]. Elevated RPR has been 
introduced as a marker of mortality by Qui et al. 
in 2017 [22]. Although RDW and platelet alone 
were not associated with prognosis, RPR was 
significantly correlated with mortality in Qiu et 
al’s study [22]. On the other hand, as a 
conflicting result, RPR of patients with and 
without irritable bowel syndrome were not 
different in a study by Atak et al. [2]. The role 
of RPR in inflammation is controversial. In a 
study it is reported that RPR was not associated 
with ovarian insufficiency, which could be an 
inflammatory process [23].  Elevated RPR was 
a marker in type 2 diabetes mellitus in Bilgin et 
al.’s study, too [21,24]. 
More importantly, both MPR and RPR were 
strongly and positively correlated with CRP 
levels in present study. They could substitute or 
may be used as addictive to CRP in determining 
morbidity and mortality in ICU patients since 
the results of hemogram tests are accessible 
within minutes, which is much shorter assay 
duration compared to CRP assay.  
Significant correlation between CRP, a well-
established mortality marker of ICU 
population, and PDW and MPV, two important 
hemogram parameters, is a very striking result 
of present study. PDW and MPV could react 
inflammatory changes in bloodstream as 
quickly as CRP. 
Limitations of present study are retrospective 
design and relatively small study population. 
Single center experience could be the third 
limitation of our work. However, to the best of 
our knowledge, this is the first study in 
literature that found significant correlation 
between CRP and hemogram parameters; MPR 
and RPR.  
In conclusion, we suggest that PDW, MPV, 
MPR and RPR could be used in determining the 
severity of the disease in ICU patients along 
with CRP. Since these hemogram results could 
be obtained in a much shorter time period 
compared to CRP, they could be useful in this 
population; in which hours and even minutes 
are important in the treatment in ICU.  
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